MDGL Stock Price
Madrigal Pharmaceuticals, Inc.
$404.95
+$5.32(+1.33%)
40
Overall
40
Value
36
Tech
44
Quality
Market Cap
$9.41B
Volume
10.41K
52W Range
$353.54 - $615.00
Target Price
$678.05
MDGL stock price is $404.95 (+1.33% on the day), giving Madrigal Pharmaceuticals, Inc. a market cap of $9.41B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
MDGL Stock Overview
- Price
- $404.95
- Previous close
- $399.63
- Open
- $411.50
- Market cap
- $9.41B
- 52-week range
- $353.54 - $615.00
- 1-year price target
- $678.05
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- Nasdaq
- MarketXLS Rank
- 40
About Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. The company offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MDGL | $404.95 | +1.3% | 10.41K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Madrigal Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW